This inventor holds 1 USPTO granted patent. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Junpei Konno: Innovator in Immunosuppressant Technology
Introduction
Junpei Konno is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunosuppressants, particularly through his innovative work on polymer derivatives. His research aims to enhance the effectiveness and safety of existing treatments.
Latest Patents
Junpei Konno holds a patent for a polymer derivative of macrolide immunosuppressant. The objective of this invention is to create a preparation that demonstrates improved effectiveness and safety compared to tacrolimus. This innovation maintains a constant concentration of the drug in the blood, eliminating the need for adjustments based on individual blood kinetics. The patent specifically relates to a polymeric derivative of tacrolimus, where a polyethylene glycol segment and an alcoholic hydroxy group of tacrolimus are bonded to side-chain carboxy groups of a polyaspartic acid derivative. He has 1 patent to his name.
Career Highlights
Junpei Konno is associated with Nippon Kayaku Kabushiki Kaisha, a company known for its advancements in pharmaceuticals and chemicals. His work at this organization has allowed him to focus on developing innovative solutions in the medical field.
Collaborations
Throughout his career, Junpei has collaborated with notable colleagues, including Akihiro Sekiguchi and Keiichirou Yamamoto. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Junpei Konno's contributions to immunosuppressant technology highlight his commitment to improving patient care through innovation. His work continues to pave the way for safer and more effective treatments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
